# PCI Pharma Services Canada, Inc. – FDA Inspection, Feb 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/pci-pharma-services-canada-inc/db327164-ec35-4180-91f4-00ce33bff91e
Source feed: FDA_Inspections

> FDA inspection 1266574 of PCI Pharma Services Canada, Inc., February 28, 2025. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266574
- Company Name: PCI Pharma Services Canada, Inc.
- Inspection Date: 2025-02-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1091465 - 2019-04-17
- FDA Inspection 852213 - 2013-09-25

## Related Officers

- [Investigator](https://www.keypedia.com/people/rose-l-jean-mary/398483f5-12f7-429b-8a13-c068b41ff3ed)

Company: https://www.keypedia.com/companies/pci-pharma-services-canada-inc/0122dddb-ebe8-44f4-bba1-9427041d01c3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c